Annual ROE
4.72%
+18.46%+134.35%
31 December 2023
Summary:
ANI Pharmaceuticals annual return on equity is currently 4.72%, with the most recent change of +18.46% (+134.35%) on 31 December 2023. During the last 3 years, it has risen by +15.76% (+142.75%). ANIP annual ROE is now -85.16% below its all-time high of 31.81%, reached on 31 December 2014.ANIP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-1.54%
-7.40%-126.28%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly return on equity is currently -1.54%, with the most recent change of -7.40% (-126.28%) on 30 September 2024. Over the past year, it has dropped by -5.05% (-143.87%). ANIP quarterly ROE is now -103.74% below its all-time high of 41.21%, reached on 31 March 2007.ANIP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +134.3% | -143.9% |
| 3 y3 years | +142.8% | +86.4% |
| 5 y5 years | -43.3% | -119.0% |
ANIP ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +130.7% | -118.7% | +93.7% |
| 5 y | 5 years | -43.3% | +130.7% | -118.7% | +93.7% |
| alltime | all time | -85.2% | +101.5% | -103.7% | +99.6% |
ANI Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -1.54%(-126.3%) |
| June 2024 | - | 5.86%(-28.7%) |
| Mar 2024 | - | 8.22%(+77.2%) |
| Dec 2023 | 4.72%(-134.4%) | 4.64%(+32.2%) |
| Sept 2023 | - | 3.51%(-343.8%) |
| June 2023 | - | -1.44%(-81.4%) |
| Mar 2023 | - | -7.75%(-44.4%) |
| Dec 2022 | -13.74%(-10.6%) | -13.95%(-35.4%) |
| Sept 2022 | - | -21.59%(-3.3%) |
| June 2022 | - | -22.33%(-8.1%) |
| Mar 2022 | - | -24.31%(+30.3%) |
| Dec 2021 | -15.37%(+39.2%) | -18.66%(+65.1%) |
| Sept 2021 | - | -11.30%(+28.3%) |
| June 2021 | - | -8.81%(+12.5%) |
| Mar 2021 | - | -7.83%(-30.8%) |
| Dec 2020 | -11.04%(-471.7%) | -11.32%(-3.4%) |
| Sept 2020 | - | -11.72%(+18.5%) |
| June 2020 | - | -9.89%(+1398.5%) |
| Mar 2020 | - | -0.66%(-122.3%) |
| Dec 2019 | 2.97%(-64.3%) | 2.96%(-63.5%) |
| Sept 2019 | - | 8.10%(-9.1%) |
| June 2019 | - | 8.91%(+24.1%) |
| Mar 2019 | - | 7.18%(-13.9%) |
| Dec 2018 | 8.33%(-1443.5%) | 8.34%(+3375.0%) |
| Sept 2018 | - | 0.24%(+242.9%) |
| June 2018 | - | 0.07%(+600.0%) |
| Mar 2018 | - | 0.01%(-101.6%) |
| Dec 2017 | -0.62%(-125.9%) | -0.61%(-114.2%) |
| Sept 2017 | - | 4.29%(+37.9%) |
| June 2017 | - | 3.11%(+38.8%) |
| Mar 2017 | - | 2.24%(-6.3%) |
| Dec 2016 | 2.39%(-76.7%) | 2.39%(-51.0%) |
| Sept 2016 | - | 4.88%(-22.2%) |
| June 2016 | - | 6.27%(-21.8%) |
| Mar 2016 | - | 8.02%(-21.8%) |
| Dec 2015 | 10.25%(-67.8%) | 10.25%(-57.8%) |
| Sept 2015 | - | 24.30%(-14.9%) |
| June 2015 | - | 28.55%(+8.9%) |
| Mar 2015 | - | 26.21%(-15.4%) |
| Dec 2014 | 31.81%(+3556.3%) | 30.98%(+100.1%) |
| Sept 2014 | - | 15.48%(+63.6%) |
| June 2014 | - | 9.46%(+28.7%) |
| Mar 2014 | - | 7.35%(-209.4%) |
| Dec 2013 | 0.87%(-101.0%) | -6.72%(-77.9%) |
| Sept 2013 | - | -30.47%(-45.1%) |
| June 2013 | - | -55.53%(-12.6%) |
| Mar 2013 | - | -63.52%(-23.4%) |
| Dec 2012 | -84.00% | -82.89%(-0.0%) |
| Sept 2012 | - | -82.93%(-27.2%) |
| June 2012 | - | -113.88%(-19.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -141.54%(-23.9%) |
| Dec 2011 | -181.20%(-31.4%) | -185.94%(-25.7%) |
| Sept 2011 | - | -250.42%(-13.4%) |
| June 2011 | - | -289.07%(+20.4%) |
| Mar 2011 | - | -240.01%(+3.8%) |
| Dec 2010 | -264.15%(-17.6%) | -231.18%(-35.0%) |
| Sept 2010 | - | -355.70%(-2.5%) |
| June 2010 | - | -364.99%(-10.9%) |
| Mar 2010 | - | -409.58%(-2.2%) |
| Dec 2009 | -320.52%(+300.5%) | -418.65%(+190.3%) |
| Sept 2009 | - | -144.23%(+15.4%) |
| June 2009 | - | -124.96%(+20.0%) |
| Mar 2009 | - | -104.15%(+25.9%) |
| Dec 2008 | -80.02%(+152.1%) | -82.74%(+13.2%) |
| Sept 2008 | - | -73.11%(+56.9%) |
| June 2008 | - | -46.59%(+34.8%) |
| Mar 2008 | - | -34.57%(+16.8%) |
| Dec 2007 | -31.74%(-241.5%) | -29.59%(-306.5%) |
| Sept 2007 | - | 14.33%(-43.9%) |
| June 2007 | - | 25.54%(-38.0%) |
| Mar 2007 | - | 41.21%(+21.6%) |
| Dec 2006 | 22.43%(-126.4%) | 33.88%(-125.3%) |
| Sept 2006 | - | -133.83%(-6.1%) |
| June 2006 | - | -142.54%(+27.0%) |
| Mar 2006 | - | -112.26%(+30.9%) |
| Dec 2005 | -84.88%(-13.1%) | -85.78%(+4.7%) |
| Sept 2005 | - | -81.92%(+9.0%) |
| June 2005 | - | -75.15%(-4.1%) |
| Mar 2005 | - | -78.36%(-3.4%) |
| Dec 2004 | -97.67%(+9.1%) | -81.15%(+16.1%) |
| Sept 2004 | - | -69.89%(-12.9%) |
| June 2004 | - | -80.22%(-28.7%) |
| Mar 2004 | - | -112.56%(+9.2%) |
| Dec 2003 | -89.56%(+1.9%) | -103.09%(+10.8%) |
| Sept 2003 | - | -93.08%(-24.5%) |
| June 2003 | - | -123.31%(+8.8%) |
| Mar 2003 | - | -113.29%(+7.7%) |
| Dec 2002 | -87.85%(+3.9%) | -105.17%(-17.1%) |
| Sept 2002 | - | -126.90%(+25.7%) |
| June 2002 | - | -100.92%(+44.0%) |
| Mar 2002 | - | -70.10%(+11.4%) |
| Dec 2001 | -84.55%(-6.8%) | -62.92%(+16.8%) |
| Sept 2001 | - | -53.89%(-37.9%) |
| June 2001 | - | -86.73%(-12.2%) |
| Mar 2001 | - | -98.77%(-1.3%) |
| Dec 2000 | -90.74%(+160.7%) | -100.05%(+54.3%) |
| Sept 2000 | - | -64.84%(+47.3%) |
| June 2000 | - | -44.01%(+199.6%) |
| Mar 2000 | - | -14.69% |
| Dec 1999 | -34.80%(-65.6%) | - |
| Dec 1998 | -101.06% | - |
FAQ
- What is ANI Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual ROE year-on-year change?
- What is ANI Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly ROE year-on-year change?
What is ANI Pharmaceuticals annual return on equity?
The current annual ROE of ANIP is 4.72%
What is the all time high annual ROE for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual return on equity is 31.81%
What is ANI Pharmaceuticals annual ROE year-on-year change?
Over the past year, ANIP annual return on equity has changed by +18.46% (+134.35%)
What is ANI Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ANIP is -1.54%
What is the all time high quarterly ROE for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly return on equity is 41.21%
What is ANI Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ANIP quarterly return on equity has changed by -5.05% (-143.87%)